InsidersTradesSigma
Beauty Health Co Stock: price and insider trades · United States · SEC (Form 4)
Track the Beauty Health Co share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Beauty Health Co has published 114 reports. Market capitalisation: €122.2m. The latest transaction was disclosed on 13 April 2026 (Retenue fiscale). Among the most active insiders: MONAHAN MICHAEL P.. Every trade is free.
114
Insider Decl.
0
Thresholds
€1m
8 ops.
Buy Volume
€20,761
1 ops.
Sell Volume
33Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,245 of 26,132 companies
41.3
score / 100
Value52
Quality31
FCF yld26%
Earn yld-7.8%
EV/EBITDA12.9x
ROE-12%
Gross mgn65%
Net mgn-3.2%
Debt/EBITDA9.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 April 2026
Declarations114 total
26,776 shares@ US$0.922.3% of flowClass A Common StockSEC:0001628280-26-024900:0
24,904 shares@ US$0.922.4% of flowClass A Common StockSEC:0001628280-26-024902:0
746,681 sharesClass A Common StockSEC:0001628280-26-020847:0
746,681 sharesClass A Common StockSEC:0001628280-26-020848:0
2,654,867 sharesClass A Common StockSEC:0001628280-26-020850:0
746,681 sharesClass A Common StockSEC:0001628280-26-020849:0
51,883 shares@ US$1.176.0% of flowClass A Common StockSEC:0001628280-26-019785:0
61,471 shares@ US$1.177.5% of flowClass A Common StockSEC:0001628280-26-019783:0
58,573 shares@ US$1.175.6% of flowClass A Common StockSEC:0001628280-26-019782:0
46,426 shares@ US$1.43Class A Common StockSEC:0001628280-25-048959:0
1,228,846 shares@ US$1.56100.0% of flowClass A Common StockSEC:0001628280-25-044806:0
32,357 shares@ US$1.894.9% of flowClass A Common StockSEC:0001628280-25-039897:0
73,051 sharesClass A Common StockSEC:0001628280-25-032138:0
73,051 sharesClass A Common StockSEC:0001628280-25-032142:0
73,051 sharesClass A Common StockSEC:0001628280-25-032141:0
73,051 sharesClass A Common StockSEC:0001628280-25-032140:0
73,051 sharesClass A Common StockSEC:0001628280-25-032139:0
73,051 sharesClass A Common StockSEC:0001628280-25-032135:0
24,290 shares@ US$1.633.7% of flowClass A Common StockSEC:0001628280-25-029044:0
31,296 shares@ US$1.083.8% of flowClass A Common StockSEC:0001628280-25-017556:0
26,776 shares@ US$1.082.9% of flowClass A Common StockSEC:0001628280-25-017546:0
92,981 shares@ US$1.083.6% of flowClass A Common StockSEC:0001628280-25-017550:0
1,832,386 shares@ US$1.3288.3% of flowClass A Common StockSEC:0001628280-25-013882:0
639,204 shares@ US$1.32100.0% of flowClass A Common StockSEC:0001628280-25-013884:0
639,204 shares@ US$1.3296.2% of flowClass A Common StockSEC:0001628280-25-013885:0
25 of 114 declarations
About Beauty Health Co
Beauty Health Co (ticker: SKIN) is a United States-based company listed on the NASDAQ market. It operates at the intersection of medical aesthetics and beauty, with a focus on professional skin-health experiences. The company is headquartered in Long Beach, California, United States. Its current corporate structure dates back to the business combination completed in May 2021 with Vesper Healthcare Acquisition Corp., which brought the company to the public markets as a category-focused skin-health platform. Operationally, Beauty Health is best known for its flagship brand Hydrafacial, a leading hydradermabrasion system that cleanses, extracts, and hydrates skin through in-office treatments. The company also markets SkinStylus, which is positioned around nanoneedling and microneedling, and Keravive, a scalp-health offering. Beauty Health designs, develops, manufactures, markets, and sells aesthetic technologies and products. For investors, the model is notable because it combines capital equipment with recurring consumables such as single-use tips, serums, and treatment solutions, creating a more durable revenue stream than a pure product-only beauty brand. From a competitive standpoint, Beauty Health occupies a niche premium position in professional skin care. Its differentiation comes from strong brand recognition around Hydrafacial, a broad provider ecosystem, and its ability to collaborate with skincare partners on co-created launches. The company’s positioning blends aesthetics, wellness, and medtech-style treatment delivery, which helps it address a wide audience across age groups, skin types, and tones. That category-creating narrative remains central to the equity story. Beauty Health’s geographic footprint is international. The company sells and places its systems worldwide and serves a global network of estheticians, medical spas, and professional treatment providers. Its strategy emphasizes expanding the installed base of delivery systems while growing consumable sales and strengthening brand awareness across existing and new geographies. Recent company disclosures and investor communications indicate continued emphasis on international expansion, operational optimization, and new product and partnership activity. In recent periods, management has highlighted efforts to widen the global footprint, improve infrastructure efficiency, and support the core Hydrafacial franchise through innovation and community investment. For international equity investors, SKIN is a growth-oriented NASDAQ-listed name in the United States that depends heavily on execution, brand strength, and the ability to convert installed systems into recurring consumable demand.
